Editas Medicine, Inc. (EDIT)

Editas Medicine Revenue

Editas Medicine had revenue of $2.83M in the quarter ending March 31, 2026, a decrease of -39.22%. This brings the company's revenue in the last twelve months to $38.69M, up 7.97% year-over-year. In the year 2025, Editas Medicine had annual revenue of $40.52M with 25.39% growth.

• Revenue (ttm): $38.69M
• Revenue Growth: +7.97%
• P/S Ratio: 9.06
• Revenue / Employee: $444,747
• Employees: 87
• Market Cap: 349.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	40.52M	8.21M	25.39%
Dec 31, 2024	32.31M	-45.81M	-58.64%
Dec 31, 2023	78.12M	58.41M	296.32%
Dec 31, 2022	19.71M	-5.83M	-22.83%
Dec 31, 2021	25.54M	-65.19M	-71.85%
Dec 31, 2020	90.73M	70.20M	341.93%
Dec 31, 2019	20.53M	-11.41M	-35.71%
Dec 31, 2018	31.94M	18.21M	132.64%
Dec 31, 2017	13.73M	7.68M	126.80%
Dec 31, 2016	6.05M	4.42M	271.58%
Dec 31, 2015	1.63M	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Data Sources Report a data error